// November 28, 2023
FDA's Draft Guidance for Topical Ophthalmic Drug Products: USP Standards
This year has seen a flurry of activity by the U.S.
This year has seen a flurry of activity by the U.S.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines c
Revised on: January 17, 2023